A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1998
11/19/1998	CA2290443A1 Peptide parathyroid hormone analogs
11/19/1998	CA2290071A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same
11/19/1998	CA2290067A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies
11/19/1998	CA2290021A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
11/19/1998	CA2289704A1 Medical uses of pyruvates
11/19/1998	CA2289573A1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
11/19/1998	CA2288850A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/19/1998	CA2288710A1 3-epi vitamin d2 compounds and uses thereof
11/19/1998	CA2288627A1 Feed composition for broilers and method for breeding broilers
11/19/1998	CA2288117A1 Tissue factor for influencing blood vessel formation
11/19/1998	CA2287923A1 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998	CA2287911A1 Apo-2 receptor
11/19/1998	CA2287363A1 Use of a pharmaceutical composition for treating and/or preventing ischemia
11/19/1998	CA2286875A1 Chemical compounds
11/19/1998	CA2282473A1 Use of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)-ethoxy)benzyl)2,4-thiazolidinedione in the treatment of polycystic ovary syndrome and gestational diabetes
11/19/1998	CA2221866A1 A novel member of the il-1 family, il-1 delta
11/18/1998	EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
11/18/1998	EP0878479A2 G-protein coupled receptor (HOFNH30)
11/18/1998	EP0878467A1 Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
11/18/1998	EP0878463A1 Excitatory amino acid receptor modulators
11/18/1998	EP0877806A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
11/18/1998	EP0877804A1 Inhibitors of cell-cycle progression, and uses related thereto
11/18/1998	EP0877760A1 Mhc complexes and uses thereof
11/18/1998	EP0877753A1 Peptide inhibitors of hematopoietic cell proliferation
11/18/1998	EP0877747A1 Azaspiro derivatives with 5ht 1b? activity
11/18/1998	EP0877744A1 Substituted aza- and diazacycloheptane and cyclooctane compounds and their use
11/18/1998	EP0877743A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1998	EP0877740A1 Thiol derivatives with metallopeptidase inhibitory activity
11/18/1998	EP0877737A1 Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity
11/18/1998	EP0877621A1 Combined pharmaceutical preparation containing lhrh-analogous substances and anti-estrogens for treating gynaecological disorders
11/18/1998	EP0877611A1 Hemoregulatory compounds
11/18/1998	EP0877610A1 Inhibitors of farnesyl-protein transferase
11/18/1998	EP0877608A1 SENSITIZATION OF HER2/neu OVER-EXPRESSING CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS
11/18/1998	EP0877605A2 Solid instant-release forms of administration and process for producing the same
11/18/1998	EP0757669B1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
11/18/1998	EP0573498B1 Aliphatic propargylamines as selective mao-b inhibitors and as neuroprotective agents
11/18/1998	CN1199396A Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases
11/18/1998	CN1199340A Analogs of parathyroid hormone
11/18/1998	CN1199337A Method of inhibiting plasminogen activator inhibitor 1
11/18/1998	CN1199045A Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
11/18/1998	CN1198945A Gingko-Ribes burejense capsule
11/18/1998	CN1198943A Soft intelligence growth promoting capsule and its preparation method
11/18/1998	CN1198941A 'Kangruling' medicine mixture
11/18/1998	CN1040753C Pyridine derivs. and preparation process thereof
11/17/1998	US5837733 Method for reducing secetion of apolipoprotein B in animals by administering conjugated linoleic acid
11/17/1998	US5837724 Administering darifenacin or salt with acetylcholinesterase inhibitor; alzheimer's disease
11/17/1998	US5837720 N-2-(pyrrolidinyl-1)-1-phenethyl) acetamides as kappa receptor antagonists
11/17/1998	US5837713 Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids
11/17/1998	US5837710 Enzyme inhibitors for treatment of aids
11/17/1998	US5837701 Diseases due to chromosomal abnormalities; administering halperidol, imipraine, trifluoperazien, aminobutyric acid, phenylalanine, vitamin e or ascorbic acid as antioxidant, folic acid, nicotinamide, lithium carbonate, carrier
11/17/1998	US5837694 Method for enhancing neurone survival and agents useful for same
11/17/1998	US5837680 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
11/17/1998	US5837532 Herpes simplex cirus type 1 mutant
11/17/1998	US5837508 Hce3p83 polypeptides and polynucleotides used in the design of protocols for treatment of alzheimer's disease, stroke, cancer, inflammation, arthritis, musculoskeletal disease, heart disease, kidney disease and diagnostic assays for such
11/17/1998	US5837499 Genetic engineering with polypeptides and dna molecules
11/17/1998	US5837498 Corpuscles of stannius protein, stanniocalcin
11/17/1998	US5837493 Human galectins
11/17/1998	US5837490 Therapeutic, diagnostic, research uses
11/17/1998	US5837486 Method for preparing soluble analogues of integrins
11/17/1998	US5837451 Identifying composition which affect kinase activity
11/17/1998	US5837449 Hybridizable oligonucleotides; genetic engineering; diagnosis, detection and treatment of brain disorders such as alzheimer*s disease
11/17/1998	US5837248 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
11/17/1998	US5837244 Treating a cell proliferative disorder
11/17/1998	CA2101356C Improvements in or relating to benzothiophenes
11/15/1998	CA2237450A1 Preparation having increased in vivo tolerability
11/13/1998	CA2237382A1 Substituted 6- and 7-amino-tetrahydroisoquinolinecarboxylic acids
11/13/1998	CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998	WO1998050572A1 HMG-CoA REDUCTASE INHIBITOR PREPARATION PROCESS
11/12/1998	WO1998050542A1 Uncoupling protein homologue: ucp 3
11/12/1998	WO1998050534A1 Protease inhibitors
11/12/1998	WO1998050435A1 Immunotoxins, comprising an onc protein, directed against malignant cells
11/12/1998	WO1998050432A1 Recombinant antibody-enzyme fusion proteins
11/12/1998	WO1998050424A2 Human serine protease precursor
11/12/1998	WO1998050420A1 Serine protease inhibitors
11/12/1998	WO1998050419A2 4-aza-steroids as inhibitors of testosterone-5-alpha-reductase
11/12/1998	WO1998050414A1 B-ring estratriene diol sulphates
11/12/1998	WO1998050413A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens
11/12/1998	WO1998050412A1 Estrogenic 19-noradnrost-17-one derivatives with an aromatic b-ring
11/12/1998	WO1998050411A1 Pharmaceutically acceptable salts of 5alpha-pregnan-3beta, 16alp ha-diol-20-one 3-sulfate useful as progestins and cns disorders
11/12/1998	WO1998050410A1 Salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity
11/12/1998	WO1998050397A2 Chimeric oligonucleotides and the use thereof
11/12/1998	WO1998050386A1 A new class of benzoporphyrin derivative photoactive compounds
11/12/1998	WO1998050385A1 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
11/12/1998	WO1998050384A1 Tricyclic pyridone analogues as gaba-a receptor ligands
11/12/1998	WO1998050383A1 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
11/12/1998	WO1998050382A1 Amidine derivatives as inhibitors of nitric oxide synthase
11/12/1998	WO1998050381A1 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
11/12/1998	WO1998050380A1 Compounds
11/12/1998	WO1998050372A1 Substituted heterocycles and their use in medicaments
11/12/1998	WO1998050370A1 Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds
11/12/1998	WO1998050367A1 Processes and intermediates for preparing substituted indazole derivatives
11/12/1998	WO1998050365A1 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents
11/12/1998	WO1998050364A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/12/1998	WO1998050363A1 Substituted tetrahydro isoquinolines as modulators of dopamine d3 receptors
11/12/1998	WO1998050358A1 Indole derivatives having combined 5ht1a, 5ht1b and 5ht1d receptor antagonist activity
11/12/1998	WO1998050356A1 2-indolinone derivatives as modulators of protein kinase activity
11/12/1998	WO1998050351A1 New cysteine derivatives, processes for their production, and pharmaceuticals containing them
11/12/1998	WO1998050342A1 Protease inhibitors
11/12/1998	WO1998050073A1 Integrin ligand, human mindin
11/12/1998	WO1998050063A1 Method of treating hyperprolactinemia and prolactinomas

1 ... 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 ... 1564